质瘤:弥合瘤微环境,患者免疫特征和新型个性化免疫疗法
Tatiana A Mishchenko1, Victoria D Turubanova1,2, Ekaterina N Gorshkova1
1Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
Frontiers in immunology
|January 26, 2024
概括
质瘤免疫疗法面临着瘤异质性和免疫抑制等挑战. 策略包括调节瘤微环境和个性化新抗原疫苗,以提高治疗疗效.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 质瘤是一种常见的大脑瘤,预后不好,死亡率高.
- 癌症免疫疗法显示出希望,但在质瘤的临床试验中面临重大挑战.
- 现有的免疫疗法尚未获得用于质瘤治疗的批准.
研究的目的:
- 审查阻碍有效质瘤免疫治疗的挑战.
- 探索克服耐药性和改善治疗结果的策略.
- 为了突出未来质瘤免疫疗法发展的方向.
主要方法:
- 讨论质瘤微环境对免疫治疗的影响.
- 重点是诱导免疫细胞死亡 (ICD),以增强免疫反应.
- 针对个性化治疗选择的免疫分析的审查.
- 探索个性化的新抗原疫苗接种策略.
主要成果:
- 质瘤微环境,特别是髓状细胞,对免疫疗法构成重大障碍.
- 诱导免疫细胞死亡可以将瘤微环境转化为"热"状态,提高免疫治疗的有效性.
- 准确的免疫分析可以指导个性化治疗,并预测患者的反应.
- 个性化新抗原疫苗为质瘤治疗提供了一个有前景的战略.
结论:
- 解决质瘤微环境中的挑战对于促进免疫疗法至关重要.
- 个性化方法,包括免疫分析和新抗原疫苗,是促进质瘤免疫疗法的关键.
- 未来的研究应该专注于克服耐药性和优化免疫治疗策略,以改善患者的生存率和生活质量.
相关概念视频
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K